Neurodiagnostics Market By Product Type (Neurodiagnostic Devices {Electroencephalography Systems, Electromyography Systems, Evoked Potential Systems, Magnetoencephalography Systems, Intracranial Pressure Monitors, Cerebral Oximeters, Transcranial Doppler Ultrasound}, Reagents & Consumables {Electrode Gels, Conductive Pastes, Needles and Electrodes}, Software & Services {Data Analysis & Interpretation Software, Cloud-Based Monitoring Systems, Maintenance & Calibration Services}), By Diagnostic Technology (Imaging-Based Diagnostics {Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Single-Photon Emission Computed Tomography} Molecular & Genetic Diagnostics {Biomarker Testing, Gene Sequencing}), By Application (Neurodegenerative Diseases, Epilepsy & Seizure Disorders, Traumatic Brain Injury, Stroke & Cerebrovascular Diseases, Sleep Disorders, Headache & Migraine Management, Psychiatric Disorders), By End User (Hospitals & Clinics, Diagnostic & Imaging Centers, Research Laboratories & Academic Institutes, Ambulatory Surgical Centers, Homecare Settings) Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Apr 2025 | Report ID: MI2532 | 210 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Neurodiagnostics Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. The increasing prevalence of neurological disorders is driving demand for neurodiagnostics.

3.2.2. Technological advancements in neuroimaging tools enhance the accuracy and efficiency of diagnostics.

3.2.3. Government funding and support for neurodiagnostics drive innovation and market development.

3.3. Key industry pitfalls & challenges

3.3.1. Regulatory barriers and lengthy approval processes delay the introduction of new technologies.

3.3.2. Data security and privacy concerns arise with the use of digital neurodiagnostic solutions.

3.3.3. A shortage of skilled professionals negatively impacts the effective use of diagnostic tools.

3.4. Market Opportunities

3.4.1. AI integration in neurodiagnostics enhances diagnostic accuracy and operational efficiencies.

3.4.2. Healthcare development in emerging markets offers new opportunities for neurodiagnostic technologies.

3.4.3. Wearable devices for continuous neurological health monitoring are driving market growth.

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Neurodiagnostics Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Neurodiagnostic Devices

4.2.1. Electroencephalography Systems

4.2.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.2. Electromyography Systems

4.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.3. Evoked Potential Systems

4.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.4. Magnetoencephalography Systems

4.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.5. Intracranial Pressure Monitors

4.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.6. Cerebral Oximeters

4.2.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.2.7. Transcranial Doppler Ultrasound

4.2.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Reagents & Consumables

4.3.1. Electrode Gels

4.3.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.2. Conductive Pastes

4.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3.3. Needles and Electrodes

4.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Software & services

4.4.1. Data Analysis & Interpretation Software Accessories

4.4.1.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.2. Cloud-Based Monitoring Systems

4.4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4.3. Maintenance & Calibration Services

4.4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Neurodiagnostics Market, Diagnostic Technology Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Diagnostic Technology, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Imaging-Based Diagnostic

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.2. Computed Tomography

5.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.3. Magnetic Resonance Imaging

5.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.4. Positron Emission Tomography

5.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.2.5. Single-Photon Emission Computed Tomography

5.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Molecular & Genetic Diagnostics

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.2. Biomarker Testing

5.3.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3.3. Gene Sequencing

5.3.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Neurodiagnostics Market, Application Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Application, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Neurodegenerative Diseases

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Epilepsy & Seizure Disorders

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion

6.4. Traumatic Brain Injury

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Stroke & Cerebrovascular Diseases

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Sleep Disorders

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.7. Headache & Migraine Management

6.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.8. Psychiatric Disorders

6.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Neurodiagnostics Market, End-user Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By End-user, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Hospitals and clinics

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Diagnostic & Imaging Centers

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Research Laboratories & Academic Institutes

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Ambulatory Surgical Centers (ASCs)

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. Homecare Settings

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Neurodiagnostics Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035(USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035(USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Diagnostic Technology, 2025-2035

8.2.4. North America Market Revenue, By Application, 2025-2035

8.2.5. North America Market Revenue, By End-user, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Diagnostic Technology, 2025-2035

8.2.6.3. U.S. Market Revenue, By Application, 2025-2035

8.2.6.4. U.S. Market Revenue, By End-user, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Diagnostic Technology, 2025-2035

8.2.7.3. Canada Market Revenue, By Application, 2025-2035

8.2.7.4. Canada Market Revenue, By End-user, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

8.3.2. Europe Market Revenue, By Product Type, 2025-2035

8.3.3. Europe Market Revenue, By Diagnostic Technology, 2025-2035

8.3.4. Europe Market Revenue, By Application, 2025-2035

8.3.5. Europe Market Revenue, By End-user, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Diagnostic Technology, 2025-2035

8.3.6.3. Germany Market Revenue, By Application, 2025-2035

8.3.6.4. Germany Market Revenue, By End-user, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Product Type, 2025-2035

8.3.7.2. France Market Revenue, By Diagnostic Technology, 2025-2035

8.3.7.3. France Market Revenue, By Application, 2025-2035

8.3.7.4. France Market Revenue, By End-user, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Diagnostic Technology, 2025-2035

8.3.8.3. U.K. Market Revenue, By Application, 2025-2035

8.3.8.4. U.K. Market Revenue, By End-user, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Diagnostic Technology, 2025-2035

8.3.9.3. Italy Market Revenue, By Application, 2025-2035

8.3.9.4. Italy Market Revenue, By End-user, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Diagnostic Technology, 2025-2035

8.3.10.3. Spain Market Revenue, By Application, 2025-2035

8.3.10.4. Spain Market Revenue, By End-user, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Diagnostic Technology, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By End-user, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Diagnostic Technology, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.5. Asia Pacific Market Revenue, By End-user, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Product Type, 2025-2035

8.4.6.2. China Market Revenue, By Diagnostic Technology, 2025-2035

8.4.6.3. China Market Revenue, By Application, 2025-2035

8.4.6.4. China Market Revenue, By End-user, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Diagnostic Technology, 2025-2035

8.4.7.3. Japan Market Revenue, By Application, 2025-2035

8.4.7.4. Japan Market Revenue, By End-user, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Product Type, 2025-2035

8.4.8.2. India Market Revenue, By Diagnostic Technology, 2025-2035

8.4.8.3. India Market Revenue, By Application, 2025-2035

8.4.8.4. India Market Revenue, By End-user, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Diagnostic Technology, 2025-2035

8.4.9.3. Australia Market Revenue, By Application, 2025-2035

8.4.9.4. Australia Market Revenue, By End-user, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Diagnostic Technology, 2025-2035

8.4.10.3. South Korea Market Revenue, By Application, 2025-2035

8.4.10.4. South Korea Market Revenue, By End-user, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Diagnostic Technology, 2025-2035

8.4.11.3. Singapore Market Revenue, By Application, 2025-2035

8.4.11.4. Singapore Market Revenue, By End-user, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Diagnostic Technology, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

8.5.2. Latin America Market Revenue, By Product Type, 2025-2035

8.5.3. Latin America Market Revenue, By Diagnostic Technology, 2025-2035

8.5.4. Latin America Market Revenue, By Application, 2025-2035

8.5.5. Latin America Market Revenue, By End-user, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Diagnostic Technology, 2025-2035

8.5.6.3. Brazil Market Revenue, By Application, 2025-2035

8.5.6.4. Brazil Market Revenue, By End-user, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Diagnostic Technology, 2025-2035

8.5.7.3. Argentina Market Revenue, By Application, 2025-2035

8.5.7.4. Argentina Market Revenue, By End-user, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Diagnostic Technology, 2025-2035

8.5.8.3. Mexico Market Revenue, By Application, 2025-2035

8.5.8.4. Mexico Market Revenue, By End-user, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

8.5.9.2. Rest of Latin America Market Revenue, By Diagnostic Technology, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Application, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By End-user, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

8.6.2. MEA Market Revenue, By Product Type, 2025-2035

8.6.3. MEA Market Revenue, By Diagnostic Technology, 2025-2035

8.6.4. MEA Market Revenue, By Application, 2025-2035

8.6.5. MEA Market Revenue, By End-user, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Diagnostic Technology, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By End-user, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Diagnostic Technology, 2025-2035

8.6.7.3. South Africa Market Revenue, By Application, 2025-2035

8.6.7.4. South Africa Market Revenue, By End-user, 2025-2035

8.6.8. Rest of Middle East & Africa

8.6.8.1. Rest of Middle East & Africa Market Revenue, By Product Type, 2025-2035

8.6.8.2. Rest of Middle East & Africa Market Revenue, By Diagnostic Technology, 2025-2035

8.6.8.3. Rest of Middle East & Africa Market Revenue, By Application, 2025-2035

8.6.8.4. Rest of Middle East & Africa Market Revenue, By End-user, 2025-2035

9. Company Profile

9.1. Siemens Healthineers

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. GE Healthcare

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Philips Healthcare

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Medtronic

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Natus

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Canon Medical Systems Corporation

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. NeuroPace

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. Compumedics Limited

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Elekta AB

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Boston Scientific

9.9.6. Business Overview

9.9.7. Financial Performance

9.9.8. Product/Service Offerings

9.9.9. Strategies & recent developments

9.9.10. SWOT Analysis

9.11. Hitachi Healthcare

9.9.11. Business Overview

9.9.12. Financial Performance

9.9.13. Product/Service Offerings

9.9.14. Strategies & recent developments

9.9.15. SWOT Analysis

9.12. Fujifilm Holdings Corporation

9.9.16. Business Overview

9.9.17. Financial Performance

9.9.18. Product/Service Offerings

9.9.19. Strategies & recent developments

9.9.20. SWOT Analysis

9.13. Neurosoft

9.9.21. Business Overview

9.9.22. Financial Performance

9.9.23. Product/Service Offerings

9.9.24. Strategies & recent developments

9.9.25. SWOT Analysis

9.14. Neurodiagnostics Inc.

9.9.26. Business Overview

9.9.27. Financial Performance

9.9.28. Product/Service Offerings

9.9.29. Strategies & recent developments

9.9.30. SWOT Analysis

9.15. Masimo Corporation

9.9.31. Business Overview

9.9.32. Financial Performance

9.9.33. Product/Service Offerings

9.9.34. Strategies & recent developments

9.9.35. SWOT Analysis

9.16. Deymed Diagnostic

1.1.1. Business Overview

1.1.2. Financial Performance

1.1.3. Product/Service Offerings